Top Legislation - View All
Also tagged in: Access to health care, Ambulatory care, Budgets, Case management, Children, Congress, Congressional reporting requirements, Continuum of care, Education, Epidemiology, Families, Family services, Federal aid to health facilities, Federal aid to research, Health education, Health policy, Higher education, Home care services, Hospital care, Maternal and infant welfare, Maternal health services, Medical care, Medical education, Medical fees, Medical research, Medical screening, Medical tests, Medicine, Mental depression, Mental health services, Mental illness, Mothers, Pharmaceutical research, Pregnancy, Quality of care, Research grants, Science policy, Social services, Women
Latest Action: 03/05/2008 - Committee on Health, Education, Labor, and Pensions. Date of scheduled consideration. SD-430. 9:30 a.m. Bill TextTo provide for research on, and services for individuals with, postpartum depression and psychosis. 10/15/2007--Passed House amended. (There is 1 other summary) Melanie Blocker-Stokes Postpartum Depression Research and Care Act - Title I: Research on Postpartum Depression and Psychosis - (Sec. 101) Encourages the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH) and the Director of the National Institute of Mental Health (NIMH), to continue aggressive work on postpartum depression and other postpartum psychosis. Encourages the Director of NIMH to continue research to expand the understanding of the causes of, and find a cure for, postpartum conditions, including: (1) basic research concerning the etiology and causes of the conditions; (2) epidemiological studies to address the frequency and natural history of the conditions and differences among racial and ethnic groups; (3) the development [...] show full description
Also tagged in: Budgets, Cancer, Chemotherapy, Child health, Children, Curricula, Education, Federal aid to research, Health education, Higher education, Medical care, Medical education, Medical research, Medicine, Pain, Pediatrics, Pharmaceutical research, Preventive medicine, Science policy
Latest Action: 09/05/2007 - Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S11119) Bill TextA resolution supporting efforts to increase childhood cancer awareness, treatment, and research. 9/5/2007--Introduced. Calls for Congress to support: (1) efforts to promote awareness about the incidence, symptoms, and options for treatment of, and long-term follow-up for, cancer among children; (2) increased investment in childhood cancer research; (3) incentives to encourage medical trainees and investigators to enter the field of pediatric oncology; (4) incentives to encourage the development of drugs and biologics designed to treat pediatric cancers; (5) policies that encourage participation in clinical trials; (6) medical education curricula designed to improve pain management for cancer patients; and (7) enhanced education, services, and other resources related to late effects from treatment.
Also tagged in: Budgets, Cancer, Chemotherapy, Child health, Children, Curricula, Education, Federal aid to research, Health education, Higher education, Medical care, Medical education, Medical research, Medicine, Pain, Pediatrics, Pharmaceutical research, Preventive medicine, Science policy
Latest Action: 09/25/2007 - Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S12075-12076) Bill TextA resolution supporting efforts to increase childhood cancer awareness, treatment, and research. 9/25/2007--Passed Senate without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Calls for Congress to support: (1) efforts to promote awareness about the incidence, symptoms, and treatment options of cancer among children; (2) increased investment in childhood cancer research; (3) incentives to encourage medical trainees and investigators to enter the field of pediatric oncology; (4) incentives to encourage the development of drugs and biologics designed to treat pediatric cancers; (5) policies that encourage participation in clinical trials; (6) medical education curricula designed to improve pain management for cancer patients; (7) enhanced education, services, and other resources related to late effects from treatment; and (8) grassroots efforts [...] show full description
Also tagged in: Armed forces, Budgets, Defense policy, Department of Health and Human Services, Education, Executive departments, Federal aid to research, Higher education, Iraq compilation, Medical care, Medical education, Medical research, Medicine, Military hospitals, Military medicine, National Institutes of Health (NIH), Pain, Research centers, Science policy, Veterans, Veterans' hospitals, Veterans' medical care
Latest Action: 09/26/2007 - Referred to the Committee on Armed Services. (text of measure as introduced: CR S12156) Bill TextA resolution expressing the sense of the Senate that the Department of Defense and the Department of Veterans Affairs should increase their investment in pain management research. 9/26/2007--Introduced. Expresses the sense of the Senate that: (1) federal funding for pain management research, treatment, and therapies, at the Department of Defense (DOD), the Department of Veterans Affairs (VA), and the National Institutes of Health (NIH) should be significantly increased; (2) Congress and the administration should redouble their efforts to ensure that a pain management program is established and implemented for military and VA treatment facilities; and (3) the DOD and VA should increase their investment in pain management clinical research.
Also tagged in: Access to health care, Budgets, Caregivers, Clinics, Communication in medicine, Communication in science, Communications, Community health services, Congress, Congressional reporting requirements, Continuing education, Department of Health and Human Services, Directories, Disabled, Education, Executive departments, Federal aid to education, Federal aid to health facilities, Federal aid to research, Government information, Government paperwork, Government publicity, Governmental investigations, Health education, Health information systems, Health planning, Health policy, Higher education, Home care services, Job training, Medical care, Medical education, Medical research, Medical technology, Medicine, Mental health services, Nervous system diseases, Neurology, Nonprofit organizations, Paralysis, Quality of life, Rehabilitation of the disabled, Research centers, Research grants, Science policy, Self-help devices for the disabled, Social services, Spinal cord injuries, Stroke, Technology, Veterans, Veterans' hospitals, Veterans' medical care, Veterans' rehabilitation
Latest Action: 03/02/2007 - Referred to the Subcommittee on Health. Bill TextTo enhance and further research into paralysis and to improve rehabilitation and the quality of life for persons living with paralysis and other physical disabilities, and for other purposes. 1/12/2007--Introduced. Christopher and Dana Reeve Quality of Life for Persons with Paralysis Act - Amends the Public Health Service Act to permit the Director of the National Institutes of Health (NIH): (1) acting through the Director of the National Institute of Neurological Disorders and Stroke, to expand and coordinate NIH activities on paralysis research; (2) to award grants to plan, establish, improve, and provide basic operating support for Christopher Reeve Paralysis Research Consortia; (3) to educate and disseminate information and receive public comment on NIH programs and research regarding paralysis; (4) acting through the Director of the National Institute on Child Health and Human Development and the National Center for Rehabilitation Research, to expand and coordinate NIH [...] show full description
Also tagged in: Administrative procedure, Auditing, Business, Cancer, Chemotherapy, Child health, Children, Communication in medicine, Communications, Congress, Congressional reporting requirements, Consumers, Data banks, Department of Health and Human Services, Drug advertising, Drug approvals, Drug industry, Executive departments, Fines (Penalties), Government information, Government paperwork, Government publicity, Governmental investigations, Health information systems, Identification devices, Law, Medical care, Medical instruments and apparatus, Medical research, Medical supplies, Medicine, National Institutes of Health (NIH), Nonprofit organizations, Periodicals, Product safety, Public contracts, Research centers, Science policy, Social services, Technology
Latest Action: 01/31/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S1449-1454) Bill TextA bill to amend the Public Health Service Act to expand the clinical trials drug data bank. 1/31/2007--Introduced. Fair Access to Clinical Trials Act of 2007 or the FACT Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to establish and operate a data bank of information on clinical trials, to include: (1) a clinical trials registry of health-related interventions conducted to test the safety or effectiveness of any drug, biological product, or device intended to treat serious or life-threatening diseases and conditions; and (2) a clinical trial results database of health-related interventions to test the safety or effectiveness of any drug, biological product, or device. Requires the Commissioner of Food and Drugs to make available to the public: (1) the full reviews conducted by the Food and Drug Administration (FDA) of new or supplemental new drug [...] show full description
Also tagged in: Administrative remedies, Advertising, Biomedical engineering, Business, Congress, Congressional reporting requirements, Consumer education, Consumers, Cost effectiveness, Data banks, Department of Health and Human Services, Drug adulteration, Drug approvals, Drug industry, Epidemiology, Executive departments, Executive reorganization, Federal advisory bodies, Finance, Fines (Penalties), Food and Drug Administration (FDA), Government information, Government paperwork, Government publicity, Health information systems, Law, Licenses, Medical care, Medical instruments and apparatus, Medical supplies, Medicine, Pharmaceutical research, Product safety, Risk, Sales promotion, Science policy, Technology
Latest Action: 01/31/2007 - Sponsor introductory remarks on measure. (CR S1454-1455) Bill TextA bill to amend the Federal Food, Drug, and Cosmetic Act with respect to drug safety, and for other purposes. 1/31/2007--Introduced. Food and Drug Administration Safety Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to establish the Center for Postmarket Evaluation and Research for Drugs and Biologics within the Food and Drug Administration (FDA). Requires the Director of the Center to conduct activities to ensure the safety and effectiveness of FDA-approved drugs and licensed biological products, including by: (1) conducting postmarket risk assessment and surveillance of such drugs and products; (2) determining whether a postmarket study is required; (3) contracting, or requiring the sponsor of such a drug or product to contract, with the holders of domestic and international patient databases to conduct epidemiologic and other observational studies; (4) determining whether a drug or product may present an unreasonable risk to the health of patients [...] show full description
Also tagged in: Biomedical engineering, Business, Conflict of interests, Congress, Congressional reporting requirements, Consumers, Corporations, Data banks, Department of Health and Human Services, Drug approvals, Drug industry, Drug interactions, Drug utilization, Drugs, Executive departments, Executive reorganization, Federal advisory bodies, Finance, Financial disclosure, Food and Drug Administration (FDA), Generic drugs, Government information, Government paperwork, Government publicity, Health information systems, Labeling, Medical care, Medical instruments and apparatus, Medical supplies, Medical technology, Medicine, Nonprofit organizations, Pharmaceutical research, Politics and government, Product development, Product safety, Research centers, Risk, Science policy, Social services, Technological innovations, Technology
Latest Action: 03/14/2007 - Committee on Health, Education, Labor, and Pensions. Hearings held. Bill TextA bill to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes. 2/1/2007--Introduced. Enhancing Drug Safety and Innovation Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to require an application for approval for a new drug or biological product to include a proposed risk evaluation and mitigation strategy, which must include: (1) labeling for the drug for use by health care providers; (2) submission of reports for the drug; and (3) a statement as to whether the analysis and surveillance are sufficient to assess the serious risks of the drug. Establishes a Drug Safety Oversight Board. Requires the Secretary of Health and Human Services to establish the Reagan-Udall Institute for Applied Biomedical Research as a nonprofit corporation to advance the Critical Path Initiative to modernize medical product development, accelerate innovation, and enhance product [...] show full description
Also tagged in: Budgets, Cancer, Chemotherapy, Child health, Children, Curricula, Education, Federal aid to research, Health counseling, Health education, Higher education, Medical care, Medical education, Medical research, Medicine, Pediatrics, Pharmaceutical research, Preventive medicine, Science policy
Latest Action: 09/25/2007 - Mr. Pallone moved to suspend the rules and agree to the resolution. Bill TextSupporting efforts to increase childhood cancer awareness, treatment, and research. 9/25/2007--Passed House without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary of that version is repeated here.) Calls for Congress to support: (1) efforts to promote awareness about the incidence, symptoms, and treatment options of cancer among children; (2) increased investment in childhood cancer research; (3) incentives to encourage medical trainees and investigators to enter the field of pediatric oncology; (4) incentives to encourage the development of drugs and biologics designed to treat pediatric cancers; (5) policies that encourage participation in clinical trials; (6) medical education curricula designed to improve pain management for cancer patients; and (7) enhanced education, services, and other resources related to late effects from treatment.
Also tagged in: Access to health care, Administrative procedure, Aged, Business, Cardiovascular diseases, Communication in medicine, Communication in science, Congress, Congressional investigations, Congressional reporting requirements, Data banks, Department of Health and Human Services, Drug approvals, Drug industry, Drugs, Education, Executive departments, Food and Drug Administration (FDA), Government information, Government paperwork, Government publicity, Governmental investigations, Health education, Health information systems, Health policy, Health surveys, Higher education, Hospital care, Indian medical care, Indian women, Indians, Law, Licenses, Medical care, Medical education, Medical instruments and apparatus, Medical malpractice, Medical records, Medical screening, Medical statistics, Medical supplies, Medical tests, Medically uninsured, Medicare, Medicine, Minorities, Minority health, Peer review organizations (Medicine), Pharmaceutical research, Physicians, Poverty, Preventive medicine, Quality of care, Science policy, Standards, Stroke, Technology, Welfare, Women, Women's health, Women's health services
Latest Action: 02/13/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women. 2/13/2007--Introduced. Heart Disease Education, Analysis Research, and Treatment for Women Act or the HEART for Women Act - Amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to require an application for approval or for investigation of a drug, device, or biological product to include information stratified by sex, race, and ethnicity, including any differences in safety and effectiveness. Requires the Secretary of Health and Human Services to: (1) withhold approval of such an application or place a clinical hold on an investigation if such information is not included; and (2) report to the scientific community and make information available to the public on such stratified data upon approval of an application.Requires the Comptroller [...] show full description
|
Latest Legislation - View All
Also tagged in: Administrative fees, Administrative remedies, Agriculture, Animals, Antibiotics, Budgets, Civil liberties, Congress, Congressional reporting requirements, Consumers, Data banks, Drug approvals, Drug resistance in microorganisms, Drugs, Food, Food safety, Generic drugs, Government information, Government publicity, Law, Livestock, Meat, Medical care, Medicine, Right of petition, Technology, User charges, Veterinary medicine
Latest Action: 08/14/2008 - Signed by President. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to revise and extend the animal drug user fee program, to establish a program of fees relating to generic new animal drugs, to make certain technical corrections to the Food and Drug Administration Amendments Act of 2007, and for other purposes. 8/14/2008--Public Law. (There are 3 other summaries) (This measure has not been amended since it was passed by the House on July 30, 2008. The summary of that version is repeated here.) Title I: Animal Drug User Fee Amendments - Animal Drug User Fee Amendments of 2008 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act to revise definitions, including defining the "process for the review of animal drug applications" to include the review of advertising and labeling prior to an approval of an animal drug application or supplemental animal application after the animal drug has been approved.(Sec. 103) Requires the [...] show full description
Also tagged in: Access to health care, Accreditation (Medical care), Administrative remedies, Adoption, Afghanistan, Aged, Aid to dependent children, Ambulances, Ambulatory care, Anesthetics, Annuities, Appropriations, Armed forces, Armed forces reserves, Barbiturates, Brain, Budgets, Business, California, Capitation (Medical care), Cardiovascular diseases, Case management, Case mix (Medical care), Cash welfare block grants, Children, Chronically ill, Civil rights, Clinics, Coinsurance, Collection of accounts, Communication in medicine, Communications, Community health services, Competitive bidding, Conflict of interests, Congregate housing, Congress, Congressional investigations, Congressional reporting requirements, Criminal justice, Defense policy, Department of Health and Human Services, Diabetes, Discrimination in medical care, District of Columbia, Drugs, Education, Electronic data interchange, Electronic government information, Estates (Law), Executive departments, Families, Federal aid to health facilities, Federal-state relations, Finance, Foster home care, Genetics, Gifts, Government information, Government procurement, Government trust funds, Governmental investigations, Group medical practice, Head injuries, Health education, Health information systems, Health insurance, Health maintenance organizations, Health policy, Hearing, Higher education, Hospital rates, Hospitals, Housing, Imaging systems in medicine, Indian medical care, Inspectors general, Insurance premiums, Iraq, Iraq compilation, Judicial review, Kidney diseases, Language and languages, Law, Life insurance, Living wills, Long-term care, Lung diseases, Managed care, Marketing, Medicaid, Medical care, Medical economics, Medical education, Medical ethics, Medical fees, Medical laboratories, Medical personnel, Medical records, Medical savings accounts, Medical statistics, Medical supplies, Medical tests, Medically uninsured, Medicare, Medicine, Medigap, Mental depression, Mental health services, Middle East and North Africa, Military occupation, Military operations, Minorities, Minority health, Nuclear medicine, Nursing homes, Obesity, Oxygen, Pensions, Performance measurement, Pharmacies, Physical examinations, Physicians, Politics and government, Post-traumatic stress disorder, Prescription pricing, Preventive medicine, Psychiatry, Psychotherapy, Psychotropic drugs, Public contracts, Quality of care, Rural affairs, Rural health, Sexual abstinence, South Asia, Speech disorders, Standards, State and local government, Subsidies, Technology, Telecommunication, Telemedicine, Terminal care, Terrorism, Translating and interpreting, Transportation, Veterans, Veterans' medical care, Welfare, Welfare eligibility, Women, Women's health
Latest Action: 07/15/2008 - Vetoed by President. Bill TextTo amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare Program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes. 7/15/2008--Public Law. (There are 3 other summaries) (This measure has not been amended since it was passed by the House on June 24, 2008. The summary of that version is repeated here.) Medicare Improvements for Patients and Providers Act of 2008 - Title I: Medicare - Subtitle A: Beneficiary Improvements - Part 1: Prevention, Mental Health, and Marketing - (Sec. 101) Amends title XVIII (Medicare) of the Social Security Act (SSA), as amended by the Medicare, Medicaid, and SCHIP Extension Act of 2007, to cover additional preventive services. Includes body mass index and end-of-life planning among initial [...] show full description
Also tagged in: Aged, Business, Consumers, Department of Health and Human Services, Drug approvals, Drug industry, Drugs, Executive departments, Executive reorganization, Federal advisory bodies, Health policy, Law, Medical care, Medical supplies, Medical technology, Medicare, Medicine, Patients' rights, Product safety, Products liability, Technology
Latest Action: 06/17/2008 - Referred to the Subcommittee on Health. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to create a new conditional approval system for drugs, biological products, and devices that is responsive to the needs of seriously ill patients, and for other purposes. 6/12/2008--Introduced. Access, Compassion, Care, and Ethics for Seriously Ill Patients Act or the ACCESS Act - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to permit an investigational drug, biological product, or device to be made available for expanded access under a treatment investigational new drug application or treatment investigational device exemption if specified Compassionate Investigational Access requirements are met.Gives immunity to the manufacturer, distributor, administrator, sponsor, or physician from suit or liability relating to products approved under this Act. Establishes a procedure for accelerated approval of an investigational drug, biological product, or device [...] show full description
Also tagged in: Aged, Alzheimer's disease, Budgets, Department of Health and Human Services, Epidemiology, Executive departments, Federal aid to health facilities, Federal aid to research, Government information, Government publicity, Health education, Hispanic Americans, Human behavior, Medical care, Medical research, Medicine, Minorities, Minority health, National Institutes of Health (NIH), Research centers, Science policy
Latest Action: 06/05/2008 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to amend the Public Health Service Act to ensure sufficient resources and increase efforts for research at the National Institutes of Health relating to Alzheimer's disease, to authorize an education and outreach program to promote public awareness and risk reduction with respect to Alzheimer's disease (with particular emphasis on education and outreach in Hispanic populations), and for other purposes. 6/5/2008--Introduced. Cure and Understanding through Research for Alzheimer's Act of 2008 or the Cura Act of 2008 - Requires the Director of the National Institutes of Health (NIH) to ensure sufficient resources for activities relating to Alzheimer's disease and Hispanic communities, including by: (1) increasing efforts in epidemiological work in Hispanic subgroups; (2) allocating resources to the National Institute on Aging Alzheimer's disease research centers and other academic centers involved in such research to increase participation of Hispanics and other underrepresented [...] show full description
Also tagged in: Aged, Alzheimer's disease, Budgets, Department of Health and Human Services, Epidemiology, Executive departments, Federal aid to health facilities, Federal aid to research, Government information, Government publicity, Health education, Hispanic Americans, Human behavior, Medical care, Medical research, Medicine, Minorities, Minority health, National Institutes of Health (NIH), Research centers, Science policy
Latest Action: 06/05/2008 - Referred to the House Committee on Energy and Commerce. Bill TextTo amend the Public Health Service Act to ensure sufficient resources and increase efforts for research at the National Institutes of Health relating to Alzheimer's disease, to authorize an education and outreach program to promote public awareness and risk reduction with respect to Alzheimer's disease (with particular emphasis on education and outreach in Hispanic populations), and for other purposes. 6/5/2008--Introduced. Cure and Understanding through Research for Alzheimer's Act of 2008 or La Cura Act of 2008 - Amends the Public Health Service Act to require the Director of the National Institutes of Health (NIH) to ensure sufficient resources for activities relating to Alzheimer's disease and Hispanic communities, including by: (1) increasing efforts in epidemiological work in Hispanic subgroups; (2) allocating resources to the National Institute on Aging Alzheimer's disease research centers and other academic centers involved in such research to increase participation [...] show full description
Also tagged in: Aged, Business, Consumers, Department of Health and Human Services, Drug approvals, Drug industry, Drugs, Executive departments, Executive reorganization, Federal advisory bodies, Health policy, Law, Medical care, Medical supplies, Medical technology, Medicare, Medicine, Patients' rights, Product safety, Products liability, Technology
Latest Action: 05/21/2008 - Sponsor introductory remarks on measure. (CR S4625) Bill TextA bill to amend the Federal Food, Drug, and Cosmetic Act to create a new conditional approval system for drugs, biological products, and devices that is responsive to the needs of seriously ill patients, and for other purposes. 5/21/2008--Introduced. Access, Compassion, Care, and Ethics for Seriously Ill Patients Act or the ACCESS Act - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to permit an investigational drug, biological product, or device to be made available for expanded access under a treatment investigational new drug application or treatment investigational device exemption if specified Compassionate Investigational Access requirements are met.Gives immunity to the manufacturer, distributor, administrator, sponsor, or physician from suit or liability relating to products approved under this Act. Establishes a procedure for accelerated approval of an investigational drug, biological product, or [...] show full description
Also tagged in: Business, Cancer, Civil rights, Collective bargaining, Congressional reporting requirements, Cost accounting, Discrimination in insurance, Discrimination in medical care, Employee health benefits, Finance, Health insurance, Health policy, Labor, Labor contracts, Medical care, Medical economics, Medical fees, Medical research, Medicine, Patients' rights, Peer review organizations (Medicine), Pharmaceutical research, Science policy, Standards
Latest Action: 05/08/2008 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group and individual health insurance coverage and group health plans to provide coverage for individuals participating in approved cancer clinical trials. 5/8/2008--Introduced. Access to Cancer Clinical Trials Act of 2008 - Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to prohibit a group health plan from: (1) denying an eligible participant or beneficiary participation in clinical trials related to the treatment of cancer that are federally funded or conducted under an investigational new drug application reviewed by the Food and Drug Administration (FDA); (2) denying (or limiting or imposing additional conditions on) the coverage of routine patient costs for items and services furnished in connection with such participation; or (3) discriminating [...] show full description
Also tagged in: Appropriations, Budgets, Department of Health and Human Services, Diseases, Executive departments, Executive reorganization, Federal advisory bodies, Federal aid to research, Governmental investigations, Medical care, Medical innovations, Medical research, Medicine, Mortality, National Institutes of Health (NIH), Preventive medicine, Public contracts, Research and development facilities, Research centers, Research grants, Science policy
Latest Action: 05/07/2008 - Sponsor introductory remarks on measure. (CR S3894) Bill TextA bill to amend the Public Health Service Act to enhance public and private research efforts to develop new tools and therapies that prevent, detect, and cure diseases. 5/7/2008--Introduced. Accelerating Cures Act of 2008 - Amends the Public Health Service Act to define "translational research" to mean research that transforms scientific discoveries arising from laboratory, clinical, or population studies into clinical application to reduce disease incidence, morbidity, and mortality.Establishes a Pathways to Cures Subcommittee within the Office of Portfolio Analysis and Strategic Initiatives (OPASI) of the National Institutes of Health (NIH) to help advise and direct translational research priorities.Requires the Director of NIH to establish a Federally Funded Research and Development Center (FFRDC) on clinical effectiveness research. Requires the Director of FFRDC to establish an independent Clinical Effectiveness Advisory Board.Requires the [...] show full description
Also tagged in: Access to health care, Alaska, Asian American ethnic groups, Blacks, Boundaries, Budgets, Child health, Children, Clinics, College administration, Commemorations, Communications, Community health services, Congressional reporting requirements, Diabetes, Diet, Education, Environmental health, Environmental protection, Epidemiology, Exercise, Federal aid to education, Federal aid to research, Food, Genetic research, Health counseling, Health education, Health policy, Health promotion, Health surveys, Higher education, Hispanic Americans, Hospital administration, Indian education, Indian medical care, Indians, Indigenous peoples, Laboratories, Latin America, Medical care, Medical education, Medical laboratories, Medical personnel, Medical research, Medical supplies, Medicine, Mentoring, Mexico, Minorities, Minorities in medicine, Minority children, Minority health, Nursing homes, Nutrition, Obesity, Pacific Islanders, Pregnancy, Pregnant women, Preventive medicine, Public health personnel, Public service advertising, Quality of care, Research grants, Scholarships, School administration, Science policy, Special days, Special weeks, Sports, Student loan funds, Teachers, Women, Women's health
Latest Action: 05/06/2008 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to amend the Public Health Service Act to prevent and cure diabetes and to promote and improve the care of individuals with diabetes for the reduction of health disparities within racial and ethnic minority groups, including the African-American, Hispanic American, Asian American and Pacific Islander, and American Indian and Alaskan Native communities. 5/6/2008--Introduced. Diabetes Prevention Access and Care Act of 2008 - Amends the Public Health Service Act to require the Director of the National Institutes of Health (NIH) to: (1) conduct, coordinate, and support research and other activities with respect to pre-diabetes and diabetes in minority populations; and (2) conduct and support programs to treat diabetes in minority populations.Requires the Director of NIH, through the National Center on Minority Health and Health Disparities, to provide for: (1) health care professionals' mentoring; and (2) minority health professionals' participation in diabetes-focused [...] show full description
Also tagged in: Business, Cytology, Human embryology, Income tax, Medical care, Medical research, Medicine, Preventive medicine, Science policy, Tax credits, Taxation
Latest Action: 04/15/2008 - Read twice and referred to the Committee on Finance. Bill TextA bill to amend the Internal Revenue Code of 1986 to provide a Federal income tax credit for certain stem cell research expenditures. 4/15/2008--Introduced. Ethical Stem Cell Research Tax Credit Act of 2008 - Amends the Internal Revenue Code to allow a tax credit for 30% of qualified stem cell research expenses paid or incurred in a taxable year. Defines "qualified stem cell research expenses" as expenses for carrying out basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of or treatments for diseases and other adverse health conditions. Prohibits a tax credit for any research expenses that may involve: (1) the creation of a human embryo for research purposes; (2) the destruction of or discarding of, or risk of injury to, a human embryo; or (3) the use of any stem cell for prohibited purposes.
|
